科思科技(688788.SH):目前公司針對專用通信領域的智能通信開發了基帶處理芯片
格隆匯5月23日丨有投資者向科思科技(688788.SH)提問:基帶芯片潛在民用領域,公司提到目前國內只有公司在開發,指的是什麼。新的基帶芯片研發是否需要制定新的行業通用標準?公司現在用的基帶芯片是什麼,未來通用性和兼容怎麼實現。
科思科技回覆:您好,感謝您的關注。目前公司針對專用通信領域的智能通信開發了基帶處理芯片。此類芯片可應用於部分特殊領域及民用領域的部分場景,如應急、户外運營商無覆蓋的場景等。新的基帶芯片研發正在參與某通信標準選型中。未來新開發的標準將和現有的協議兼容。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.